Blue Therapeutics

Blue Therapeutics Overview

Founded 2014
Status Private
Employees 4
Latest Deal Type Grant
Investors 4

Blue Therapeutics General Information


Operator of a drug development company intended to pursue treatment options for patients in pain. The company's drug involves production of highly effective and non-addictive painkillers of non-narcotic small molecules with potent analgesic properties that reduces the unwanted side effects, enabling patients to be pain-free without the risk of dependency.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Primary Office
  • 114 Western Avenue
  • Boston, MA 02134
  • United States
+1 (617) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Blue Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant Completed Startup
4. Grant 01-Jan-2016 00000 Completed Startup
3. Accelerator/Incubator 20-May-2015 Completed Startup
2. Grant 30-Apr-2015 $5K Completed Startup
1. Accelerator/Incubator Completed Startup

Blue Therapeutics Executive Team (4)

Name Title Board Seat Contact Info
Michio Painter Ph.D Co-Founder & Chief Executive Officer
David Roberson Ph.D Co-Founder & Chief Operating Officer
Ajay Yekkirala Ph.D Co-Founder & Chief Scientific Officer

1 Former Executive

Blue Therapeutics Investors (4)

To view Blue Therapeutics‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
MassChallenge Accelerator/Incubator 000 0000 000000 0
Harvard Innovation Launch Lab Accelerator/Incubator Minority 000 0000 000000 0
The Roddenberry Foundation Corporation 000 0000 000000 0

Ready to get started?

Request a free trial